Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2)

INTRODUCTION: The antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease (APPLE COPD-ICON2) trial is a prospective 2×2 factorial, double-blinded proof-of-concept randomised controlled trial targeting patients with chronic obstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunadian, Vijay, Chan, Danny, Ali, Hani, Wilkinson, Nina, Howe, Nicola, McColl, Elaine, Thornton, Jared, von Wilamowitz-Moellendorff, Alexander, Holstein, Eva-Maria, Burns, Graham, Fisher, Andrew, Stocken, Deborah, De Soyza, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988059/
https://www.ncbi.nlm.nih.gov/pubmed/29804061
http://dx.doi.org/10.1136/bmjopen-2017-020713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988059/
https://www.ncbi.nlm.nih.gov/pubmed/29804061
http://dx.doi.org/10.1136/bmjopen-2017-020713

Ejemplares similares